Brain,
Journal Year:
2017,
Volume and Issue:
140(12), P. 3252 - 3268
Published: Oct. 5, 2017
The
Dlg4
gene
encodes
for
post-synaptic
density
protein
95
(PSD95),
a
major
synaptic
that
clusters
glutamate
receptors
and
is
critical
plasticity.
PSD95
levels
are
diminished
in
ageing
neurodegenerative
disorders,
including
Alzheimer's
disease
Huntington's
disease.
epigenetic
mechanisms
(dys)regulate
transcription
of
Dlg4/PSD95,
or
other
plasticity
genes,
largely
unknown,
limiting
the
development
targeted
epigenome
therapy.
We
analysed
Dlg4/PSD95
landscape
hippocampal
tissue
designed
gene-targeting
strategy:
zinc
finger
DNA-binding
domain
was
engineered
fused
to
effector
domains
either
repress
(G9a,
Suvdel76,
SKD)
activate
(VP64)
transcription,
generating
artificial
factors
editors
(methylating
H3K9).
These
epi-editors
altered
histone
marks
subsequently
expression,
which,
importantly,
impacted
several
neuron
processes.
Intriguingly,
transduction
factor
PSD95-VP64
rescued
memory
deficits
aged
mice.
Conclusively,
this
work
validates
as
key
player
establishes
editing
potential
therapy
treat
human
neurological
disorders.
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: Aug. 30, 2023
Major
depressive
disorder
(MDD)
is
a
chronic,
generally
episodic
and
debilitating
disease
that
affects
an
estimated
300
million
people
worldwide,
but
its
pathogenesis
poorly
understood.
The
heritability
estimate
of
MDD
30-40%,
suggesting
genetics
alone
do
not
account
for
most
the
risk
major
depression.
Another
factor
known
to
associate
with
involves
environmental
stressors
such
as
childhood
adversity
recent
life
stress.
Recent
studies
have
emerged
show
biological
impact
factors
in
other
stress-related
disorders
mediated
by
variety
epigenetic
modifications.
These
modification
alterations
contribute
abnormal
neuroendocrine
responses,
neuroplasticity
impairment,
neurotransmission
neuroglia
dysfunction,
which
are
involved
pathophysiology
MDD.
Furthermore,
marks
been
associated
diagnosis
treatment
evaluation
modifications
holds
promise
further
understanding
heterogeneous
etiology
complex
phenotypes
MDD,
may
identify
new
therapeutic
targets.
Here,
we
review
preclinical
clinical
findings,
including
DNA
methylation,
histone
modification,
noncoding
RNA,
RNA
chromatin
remodeling
In
addition,
elaborate
on
contribution
these
mechanisms
pathological
trait
variability
depression
discuss
how
can
be
exploited
purposes.
BioSocieties,
Journal Year:
2014,
Volume and Issue:
9(4), P. 431 - 456
Published: Aug. 4, 2014
Epigenetics
is
one
of
the
most
rapidly
expanding
fields
in
life
sciences.
Its
rise
frequently
framed
as
a
revolutionary
turn
that
heralds
new
epoch
both
for
gene-based
epistemology
and
wider
discourse
on
pervades
knowledge-intensive
societies
molecular
age.
The
fundamentals
this
revolution
remain
however
to
be
scrutinized,
indeed
very
contours
what
counts
'epigenetic'
are
often
blurred.
This
reflected
also
mounting
societal
implications
epigenetics,
which
vast
expectations
coexist
with
significant
uncertainty
about
aspects
science
relevant
politics
or
policy
alike.
therefore
suitable
time
reflect
directions
social
theory
could
productively
take
scrutiny
revolution.
Here
we
opportunity
its
scholarly
normative
dimension,
is,
proposing
roadmap
theorizing
epigenetics
does
not
shy
away
from,
hopefully
guides,
framing
socially
outputs.
To
end,
start
an
epistemological
reappraisal
epigenetic
valorizes
blurring
meanings
critical
asset
field
privileged
analytical
entry
point.
We
then
propose
three
paths
investigation.
first
looks
at
structuring
elements
controversies
visions
around
epigenetics.
second
probes
mutual
constitution
between
reordering
living
phenomena
settlements
orient
individual
collective
responsibilities.
third
highlights
material
import
molecularization
culture
it
mediates.
suggest
these
complementary
strands
provide
epistemically
self-reflective
framework
advance
study
juncture
nature
nurture
thus
frontier
studies
Current Neuropharmacology,
Journal Year:
2017,
Volume and Issue:
15(7)
Published: March 15, 2017
Alzheimer's
disease
(AD)
is
a
chronic,
progressive
and
prevalent
neurodegenerative
characterized
by
the
loss
of
higher
cognitive
functions
an
associated
memory.
The
thus
far
"incurable"
stigma
for
AD
prevails
because
variations
in
success
rates
different
treatment
protocols
animal
human
studies.
Among
classical
hypotheses
explaining
pathogenesis,
amyloid
hypothesis
currently
being
targeted
drug
development.
underlying
concept
to
prevent
formation
these
neurotoxic
peptides
which
play
central
role
pathology
trigger
multispectral
cascade
processes
post-aggregation.
This
could
possibly
be
achieved
pharmacological
inhibition
β-
or
γ-secretase
stimulating
nonamyloidogenic
α-secretase.
Melatonin
pineal
hormone
multifunctioning
indoleamine.
Production
this
amphiphilic
molecule
diminishes
with
advancing
age
decrease
runs
parallel
progression
itself
explains
potential
benefits
melatonin
line
development
devastating
consequences
progression.
Our
recent
studies
have
revealed
novel
mechanism
stimulates
processing
inhibits
amyloidogenic
β-amyloid
precursor
protein
(βAPP)
α
-secretases
consequently
down
regulating
both
γ-secretases
at
transcriptional
level.
In
review,
we
discuss
evaluate
neuroprotective
including
its
cellular
models
clinical
interventions
patients,
suggest
that
early
detection,
qualified
anti-AD
therapy.
Keywords:
disease,
aging,
amyloid-β
peptide,
melatonin,
secretases,
neuroprotection.
Brain,
Journal Year:
2017,
Volume and Issue:
140(12), P. 3252 - 3268
Published: Oct. 5, 2017
The
Dlg4
gene
encodes
for
post-synaptic
density
protein
95
(PSD95),
a
major
synaptic
that
clusters
glutamate
receptors
and
is
critical
plasticity.
PSD95
levels
are
diminished
in
ageing
neurodegenerative
disorders,
including
Alzheimer's
disease
Huntington's
disease.
epigenetic
mechanisms
(dys)regulate
transcription
of
Dlg4/PSD95,
or
other
plasticity
genes,
largely
unknown,
limiting
the
development
targeted
epigenome
therapy.
We
analysed
Dlg4/PSD95
landscape
hippocampal
tissue
designed
gene-targeting
strategy:
zinc
finger
DNA-binding
domain
was
engineered
fused
to
effector
domains
either
repress
(G9a,
Suvdel76,
SKD)
activate
(VP64)
transcription,
generating
artificial
factors
editors
(methylating
H3K9).
These
epi-editors
altered
histone
marks
subsequently
expression,
which,
importantly,
impacted
several
neuron
processes.
Intriguingly,
transduction
factor
PSD95-VP64
rescued
memory
deficits
aged
mice.
Conclusively,
this
work
validates
as
key
player
establishes
editing
potential
therapy
treat
human
neurological
disorders.